1921
Volume 76, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

The requirements for effective and efficient intracellular killing of by activated macrophages are unknown. Despite resistance to the arginase inhibitor LOHA by intracellular amastigotes, enhanced replication did not account for the relative resistance of this parasite to macrophage activation. Herein we report that the presence of both superoxide and nitric oxide is necessary for efficient killing of amastigotes within LPS/IFN-γ–activated bone marrow-derived macrophages generated from C3H mice. Addition of an extracellular signal-regulated kinase (ERK) inhibitor to infected macrophages increased the ability of these activated macrophages to kill amastigotes. This enhanced macrophage killing through addition of ERK inhibitor was abrogated by inhibition of superoxide or iNOS, whereas inhibiting superoxide had no effect on the killing of . These results suggest that ERK activation may modulate effective macrophage killing, leading to the ability of to resist elimination within activated macrophages.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.2007.76.669
2007-04-01
2017-09-19
Loading full text...

Full text loading...

/deliver/fulltext/14761645/76/4/0760669.html?itemId=/content/journals/10.4269/ajtmh.2007.76.669&mimeType=html&fmt=ahah

References

  1. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY, 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375 : 408–411.
  2. Murray HW, Nathan CF, 1999. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 189 : 741–746.
  3. Stenger S, Donhauser N, Thuring H, Rollinghoff M, Bogdan C, 1996. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med 183 : 1501–1514.
  4. Linares E, Giorgio S, Mortara RA, Santos CX, Yamada AT, Augusto O, 2001. Role of peroxynitrite in macrophage microbicidal mechanisms in vivo revealed by protein nitration and hydroxylation. Free Radic Biol Med 30 : 1234–1242.
  5. Bogdan C, Rollinghoff M, Diefenbach A, 2000. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 12 : 64–76.
  6. Blos M, Schleicher U, Soares Rocha FJ, Meissner U, Rollinghoff M, Bogdan C, 2003. Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase. Eur J Immunol 33 : 1224–1234.
  7. Iniesta V, Gomez-Nieto LC, Corraliza I, 2001. The inhibition of arginase by N(omega)-hydroxy-l-arginine controls the growth of Leishmania inside macrophages. J Exp Med 193 : 777–784.
  8. Mukbel R, Petersen CA, Jones DE, 2006. Soluble factors from Leishmania major-specific CD4+ T cells and B cells limit L. amazonensis amastigote survival within infected macrophages.Microbes Infect 8 : 2547–2555.
  9. Stafford JL, Neumann NF, Belosevic M, 2002. Macrophage-mediated innate host defense against protozoan parasites. Crit Rev Microbiol 28 : 187–248.
  10. Feng GJ, Goodridge HS, Harnett MM, Wei XQ, Nikolaev AV, Higson AP, Liew FY, 1999. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase. J Immunol 163 : 6403–6412.
  11. Mathur RK, Awasthi A, Wadhone P, Ramanamurthy B, Saha B, 2004. Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses. Nat Med 10: 540–544. Epub 2004 Apr 25.
  12. Olivier M, Gregory DJ, Forget G, 2005. Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view. Clin Microbiol Rev 18 : 293–305.
  13. Vanloubbeeck Y, Jones DE, 2004. Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection. Am J Trop Med Hyg 71 : 407–411.
  14. Sacks D, 2003. Experimental Leishmania infection. Coligan J, Kruisbeek A, Margulies D, Shevach E, Strober W, eds. Current Protocols in Immunology. New York: Wiley.
  15. Migliorini P, Corradin G, Corradin SB, 1991. Macrophage NO2 production as a sensitive and rapid assay for the quantitation of murine IFN-gamma. J Immunol Methods 139 : 107–114.
  16. Melo EJ, Beiral HJ, 2003. Effect of hydroxyurea on the intracellular multiplication of Toxoplasma gondii, Leishmania amazonensis and Trypanosoma cruzi. Braz J Med Biol Res 36 : 65–69.
  17. Gomes IN, Calabrich AF, Tavares R da S, Wietzerbin J, Freitas LAR, Veras PS, 2003. Differential properties of CBA/J mono-nuclear phagocytes recovered from an inflammatory site and probed with two different species of Leishmania. Microbes Infect 5 : 251–260.
  18. Murphy ML, Wille U, Villegas EN, Hunter CA, Farrell JP, 2001. IL-10 mediates susceptibility to Leishmania donovani infection. Eur J Immunol 31 : 2848–2856.
  19. Cunha FQ, Moncada S, Liew FY, 1992. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun 182 : 1155–1159.
  20. Kane MM, Mosser DM, 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 166 : 1141–1147.
  21. Holzmuller P, Sereno D, Cavaleyra M, Mangot I, Daulouede S, Vincendeau P, Lemesre JL, 2002. Nitric oxide-mediated proteasome-dependent oligonucleosomal DNA fragmentation in Leishmania amazonensis amastigotes. Infect Immun 70 : 3727–3735.
  22. Holzmuller P, Bras-Goncalves R, Lemesre JL, 2006. Phenotypical characteristics, biochemical pathways, molecular targets and putative role of nitric oxide-mediated programmed cell death in Leishmania. Parasitology 132 : S19–S32.
  23. Qi H, Ji J, Wanasen N, Soong L, 2004. Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis. Infect Immun 72 : 988–995.
  24. Martiny A, Meyer-Fernandes JR, de Souza W, Vannier-Santos MA, 1999. Altered tyrosine phosphorylation of ERK1 MAP kinase and other macrophage molecules caused by Leishmania amastigotes. Mol Biochem Parasitol 102 : 1–12.
  25. Cameron P, McGachy A, Anderson M, Paul A, Coombs GH, Mottram JC, Alexander J, Plevin R, 2004. Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway. J Immunol 173 : 3297–3304.
  26. Ghosh S, Bhattacharyya S, Sirkar M, Sa GS, Das T, Majumdar D, Roy S, Majumdar S, 2002. Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase. Infect Immun 70 : 6828–6838.
  27. Nandan D, Lo R, Reiner NE, 1999. Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect Immun 67 : 4055–4063.
  28. Gazzinelli RT, Oswald IP, James SL, Sher A, 1992. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. J Immunol 148 : 1792–1796.
  29. Marikovsky M, Ziv V, Nevo N, Harris-Cerruti C, Mahler O, 2003. Cu/Zn superoxide dismutase plays important role in immune response. J Immunol 170 : 2993–3001.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.2007.76.669
Loading
/content/journals/10.4269/ajtmh.2007.76.669
Loading

Data & Media loading...

  • Received : 14 Jul 2005
  • Accepted : 08 Dec 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error